Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program

Abstract

In this study involving a population assisted by a primary care program, CKD was confirmed as an independent risk factor for CVD. The presence of MS concurrent with CKD substantially amplified the risk for CVD.

The Influence of Vasoconstritor Use in Local Anesthesia in Individuals with Chronic Renal Failure

“…Among the most frequent comorbidities is SAH 2,4-7 , which in this study was associated with CRF in 70% ( 14) of the individuals, consistent with the constancy already described in the literature 6.7 . In relation to the incidence of DM in the present study, 35% (7) of individuals reported having the disease, being the second most frequently associated comorbidity, as well as previously described in the literature 2,[5][6][7][8]25 . Such information alert to cases of more invasive procedures, taking into account the possible need for control of SAH and the relationship of the DM on the healing repair.…”

“…Individuals with CRF under HD suffer for years with the disease and its treatment, which leads them to develop various physical, psychological and social problems, directly affecting the quality of life of these, their families, and possibly of society as a whole 5,[20][21][22][23][24] .…”

“…It is also emphasized that the frequent association of individuals with CRF under HD to SAH, widely described in the literature [4][5][6][7] , requires that multiple care be considered such as consideration to heparin used in HD, the control of systemic arterial pressure and the use of anesthetics with or without vasoconstrictor, according to the type and duration of…”

“…Individuals with CRF often have SAH, which determines a more careful choice of anesthetics to be used 2,[5][6][7] . Due to the need of dental care, the dental surgeon, requires the use of local anesthetics for the realization of various procedures the choice of anesthetic to be used should consider the anesthetic potency, latency (time of onset of anesthesia), duration of the anesthetic effect, the pharmacokinetics (absorption, distribution, metabolism and excretion) and toxicity 13 .…”

Is Obesity a Risk Factor in COVID-19 Pandemic?

“…Ancak yapılan çalışmalar çoğunlukla, insülin direnci veya metabolik sendrom varlığı ile birlikte artan BKİ değerlerinin kardiyovasküler riski artırdığını göstermektedir. 72,73 Bunun yanında 43 adet follow-up çalışmanın meta-analiz sonuçları, metabolik olarak sağlıklı kişilerde artan BKİ ile kardiyovasküler riskin de artabileceğini göstermektedir. 74 Dolayısıyla obezite tek başına dahi kardiyovasküler hastalık açısından risk faktörü olarak değerlendirilmektedir.…”